Most Popular Stories
- How much cheaper will biosimilars be?
- Universal vaccine could cut flu across the whole community
- Chinese pharmas feel the squeeze of healthcare reform
- Abbott banks on boomers with $270M nutrition facility
- Columbia Labs to cut 42% of workforce after FDA snub
- NIH backs effort to integrate clinical trials data into EHRs
- Roche arthritis drug beats Humira in clinical study
- Gov't advisor calls on FDA to boost clinical trials of drugs in kids
- Ex-Amgen R&D chief Perlmutter in talks with other companies about next move
- Bioethicist quits job at controversial stem cell outfit
- Columbia Labs axing 42% of jobs after FDA shoots down drug application
Webinars
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
Events
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- The Cutting Edge of Chemistry
- The National Provider Identifier (NPI) and its Impact on the Pharmaceutical and Medical Device Industries
- Displacement Chromatography Comes of Age - An indispencable tool for the purification of biomacromolecules
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
- Commercial Insight: Top 20 Cancer Therapy Brands
- WHITE PAPER: Four Strategies for Cost-Effective Pharmacovigilance
10 mobile apps in life sciences
SmartReports Mobile - 10 mobile apps in life sciences
Company: PHT Corporation
Platform: Available free through StudyWorks, PHT’s online system accessible with their products two products: the LogPad system and the SitePad tablet
Release date: September 2011
Scoop: This ePRO smartphone application can check that sites and subjects are compliant with specific protocol and can locate those subjects that need more study. And with a one-tap function, those users in compliance monitoring can contact the trial site in order to communicate about and expedite a solution for any issues. The GPS capability within the app allows the user to find and contact the site quickly and easily from their mobile device.
SHARE
WITH: